Vaccinex Stock (NASDAQ: VCNX) stock price, news, charts, stock research, profile.
Open | $4.800 |
Close | - |
Volume / Avg. | 3.457K / 13.301K |
Day Range | 4.740 - 5.100 |
52 Wk Range | 4.432 - 100.800 |
Market Cap | $7.288M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 27 |
Short Interest | 0.76% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vaccinex (NASDAQ: VCNX) through any online brokerage.
Other companies in Vaccinex’s space includes: Virios Therapeutics (NASDAQ:VIRI), Can Fite Biofarma (AMEX:CANF), BioRestorative Therapies (NASDAQ:BRTX), NuCana (NASDAQ:NCNA) and Longeveron (NASDAQ:LGVN).
The latest price target for Vaccinex (NASDAQ: VCNX) was reported by Oppenheimer on Friday, September 25, 2020. The analyst firm set a price target for 7.00 expecting VCNX to rise to within 12 months (a possible 52.17% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Vaccinex (NASDAQ: VCNX) is $4.6 last updated April 22, 2024 at 6:14 PM EDT.
There are no upcoming dividends for Vaccinex.
Vaccinex’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Vaccinex.
Vaccinex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.